Equities

Craneware PLC

CRW:LSE

Craneware PLC

Health CareHealth Care Providers
  • Price (GBX)1,570.00
  • Today's Change-30.00 / -1.88%
  • Shares traded439.20k
  • 1 Year change-12.53%
  • Beta0.0055
Data delayed at least 20 minutes, as of Feb 06 2026 16:01 GMT.
More ▼

Forecasts data is unavailable for this security.

Consensus recommendation

  • 20-Feb-25
  • 20-Nov-25
  • 18-Dec-25
  • 15-Jan-26
  • 05-Feb-26
Select bar for recommendation details.
Recommendations05-Feb-26
Buy3
Outperform2
Hold0
Sell0
Strong Sell0

Share price forecast

The 4 analysts offering 12 month price targets for Craneware plc have a median target of 2,911.63, with a high estimate of 3,330.01 and a low estimate of 2,875.41. The median estimate represents a 85.45% increase from the last price of 1,570.00.
High112.1%3,330.01
Med85.5%2,911.63
Low83.1%2,875.41

Dividends

In 2025, Craneware PLC reported a dividend of 0.44 USD, which represents a 19.87% increase over last year. The 5 analysts covering the company expect dividends of 0.42 USD for the upcoming fiscal year, a decrease of 4.43%.
Div growth (TTM)19.87%
More ▼

Earnings history & estimates

Craneware plc reported annual 2025 earnings of 1.14 per share on Sep 15, 2025.
Average growth rate+14.49%
More ▼

Revenue history & estimates

Craneware plc had revenues for the full year 2025 of 205.66m. This was 8.66% above the prior year's results.
Average growth rate+35.39%
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.